−0.9061USD
−7.94 MUSD
2.53 MUSD
5.86 M
About bioAffinity Technologies, Inc.
Sector
Industry
CEO
Maria Zannes
Website
Headquarters
San Antonio
Employees (FY)
75
Founded
2014
FIGI
BBG018DZJPN8
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
